Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.
about
Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like StimulantsGone to Pot - A Review of the Association between Cannabis and PsychosisΔ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.Cannabis cue reactivity and craving among never, infrequent and heavy cannabis usersThe psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humansEffects of 20 mg oral Δ(9) -tetrahydrocannabinol on the olfactory function of healthy volunteers.Impact of Cannabis Use on the Development of Psychotic DisordersDelta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosisThe utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2An Event-Related Potential Study on the Effects of Cannabis on Emotion Processing.Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and SchizophreniaCannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats.The early identification of psychosis: can lessons be learnt from cardiac stress testing?Acute effects of THC on time perception in frequent and infrequent cannabis usersBrain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix.GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC.Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.Neural correlates of performance monitoring in chronic cannabis users and cannabis-naive controls.Effects of cannabis use and subclinical depression on the P3 event-related potential in an emotion processing task.Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene.Acute effects of cocaine and cannabis on response inhibition in humans: an ERP investigation.Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity.The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review.Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia.Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.
P2860
Q26752739-F2B89993-0000-4396-B7C1-A447D0484268Q26865311-814612BB-8821-4112-9D85-FD9043DE1A5EQ30377901-F745DEDC-D212-4E9B-A93A-892210FC540BQ30415507-ADC451BB-8B83-49F0-9862-10F6D75A70B7Q30671268-500B11F9-0067-45F9-88C2-B0EA45532435Q34570852-720C3456-0188-4B0C-9E9F-FA41AFC66C1DQ34668606-BAA10EDF-51BD-4E54-9DE4-03D32441D08CQ34996731-2F6BCE9D-FA17-4C2B-9B1C-97B86C22B617Q35243586-B4EC5AFA-69DA-4BD1-80A7-FB7C7CE9AE15Q35939732-5737AD9C-34FB-4B3A-81F7-F78F2B2FE618Q35990574-57496D14-8126-4F63-9BAA-FFF523796A60Q36267309-09906C90-9AB4-44AE-B944-A9888F840A35Q36437209-0D74F9AD-D03F-42BC-8490-BCFA62ECD091Q36636653-1AF402BC-45C8-45FF-B328-1E88C0EECE5CQ36799066-73B11008-4912-4F99-A884-F58A022AD797Q36821827-1E064EDD-1B33-4A00-B72B-C583400A3BABQ36945634-9B9D8F17-A80D-4B72-ADC1-5C53E0F232A3Q37274656-8BCFA838-E891-40AA-AF64-C087FFB07C3BQ37581910-8EB6196A-11C2-4239-ABCF-371C7228E917Q37727255-8EBEAC49-02E3-4CF6-8D54-DDC7A4FB7593Q41152430-A482BAFD-EE8C-4642-8E60-C6CC3EDE7592Q44193796-0D7BBA5D-52A8-4F42-8911-11F090906C8AQ47373781-10E05034-5974-4FDD-8B5B-16883FA24966Q47762220-2F21BF91-BF80-4F87-9C92-538633935707Q50533341-6EB9A4E8-0C2E-419A-8CFD-F0766DD174B2Q52151974-E4B3F6F5-FE83-40D8-9E0C-234AC0133EBAQ52616960-CB223914-369E-4852-9025-A363E5BD127AQ52861250-C9264918-192D-4471-A405-C64D3915EE78
P2860
Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Dose-related modulation of eve ...... intravenous Δ⁹-THC in humans.
@ast
Dose-related modulation of eve ...... intravenous Δ⁹-THC in humans.
@en
type
label
Dose-related modulation of eve ...... intravenous Δ⁹-THC in humans.
@ast
Dose-related modulation of eve ...... intravenous Δ⁹-THC in humans.
@en
prefLabel
Dose-related modulation of eve ...... intravenous Δ⁹-THC in humans.
@ast
Dose-related modulation of eve ...... intravenous Δ⁹-THC in humans.
@en
P2093
P2860
P356
P1476
Dose-related modulation of eve ...... intravenous Δ⁹-THC in humans.
@en
P2093
Ashley Schnakenberg
Ashley Williams
Brian Pittman
Brian Roach
Daniel J Fridberg
Daniel Mathalon
Deepak Cyril D'Souza
Jacqueline Elander
Michelle Carbuto
Mohini Ranganathan
P2860
P2888
P304
P356
10.1038/NPP.2012.8
P407
P577
2012-02-15T00:00:00Z
P5875
P6179
1048672888